The stock of Thermo Fisher Scientific Inc (TMO) has gone up by 0.76% for the week, with a -7.16% drop in the past month and a -16.34% drop in the past quarter. The volatility ratio for the week is 1.72%, and the volatility levels for the past 30 days are 2.10% for TMO. The simple moving average for the last 20 days is -4.06% for TMO stock, with a simple moving average of -11.12% for the last 200 days.
Is It Worth Investing in Thermo Fisher Scientific Inc (NYSE: TMO) Right Now?
Thermo Fisher Scientific Inc (NYSE: TMO) has a higher price-to-earnings ratio of 32.17x compared to its average ratio, The 36-month beta value for TMO is at 0.77. Analysts have varying views on the stock, with 17 analysts rating it as a “buy,” 8 rating it as “overweight,” 6 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TMO is 381.97M, and currently, shorts hold a 0.77% of that float. The average trading volume for TMO on November 27, 2024 was 1.43M shares.
TMO) stock’s latest price update
Thermo Fisher Scientific Inc (NYSE: TMO) has seen a decline in its stock price by -0.24 in relation to its previous close of 514.20. However, the company has experienced a 0.76% gain in its stock price over the last five trading sessions. zacks.com reported 2024-11-20 that A few of its recent strategic acquisitions that are likely to drive future growth for TMO include the $3.1-billion acquisition of Olink Holdings.
Analysts’ Opinion of TMO
Stephens, on the other hand, stated in their research note that they expect to see TMO reach a price target of $680. The rating they have provided for TMO stocks is “Overweight” according to the report published on October 01st, 2024.
Wells Fargo gave a rating of “Overweight” to TMO, setting the target price at $670 in the report published on August 28th of the current year.
TMO Trading at -10.28% from the 50-Day Moving Average
After a stumble in the market that brought TMO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.30% of loss for the given period.
Volatility was left at 2.10%, however, over the last 30 days, the volatility rate increased by 1.72%, as shares sank -6.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.97% lower at present.
During the last 5 trading sessions, TMO rose by +0.76%, which changed the moving average for the period of 200-days by -6.20% in comparison to the 20-day moving average, which settled at $534.69. In addition, Thermo Fisher Scientific Inc saw -3.36% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TMO starting from CASPER MARC N, who sale 9,000 shares at the price of $552.86 back on Nov 08 ’24. After this action, CASPER MARC N now owns 14,608 shares of Thermo Fisher Scientific Inc, valued at $4,975,765 using the latest closing price.
CASPER MARC N, the Officer of Thermo Fisher Scientific Inc, proposed sale 9,000 shares at $552.86 during a trade that took place back on Nov 08 ’24, which means that CASPER MARC N is holding shares at $4,975,753 based on the most recent closing price.
Stock Fundamentals for TMO
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.41 for the gross margin
The net margin for Thermo Fisher Scientific Inc stands at 0.14. The total capital return value is set at 0.08. Equity return is now at value 13.01, with 6.22 for asset returns.
Based on Thermo Fisher Scientific Inc (TMO), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 4.9.
Currently, EBITDA for the company is 11.2 billion with net debt to EBITDA at 2.71. When we switch over and look at the enterprise to sales, we see a ratio of 5.35. The receivables turnover for the company is 4.33for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In conclusion, Thermo Fisher Scientific Inc (TMO) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
